Products Affected - Description

• • Isovue-200 solution for injection, Bracco Diagnostics, 41%, 200 mL single dose glass bottle, 10 count, NDC 00270-1314-15
  • Isovue-250 solution for injection, Bracco Diagnostics, 51%, 100 mL single dose glass bottle, 10 count, NDC 00270-1317-02
  • Isovue-300 solution for injection, Bracco Diagnostics, 61%, 100 mL single dose glass bottle, 10 count, NDC 00270-1315-35
  • Isovue-300 solution for injection, Bracco Diagnostics, 61%, 200 mL imaging bulk package glass bottle, 10 count, NDC 00270-1315-45
  • Isovue-300 solution for injection, Bracco Diagnostics, 61%, 30 mL single dose vial, 10 count, NDC 00270-1315-25
  • Isovue-300 solution for injection, Bracco Diagnostics, 61%, 500 mL imaging bulk package glass bottle, 6 count, NDC 00270-1315-95
  • Isovue-370 solution for injection, Bracco Diagnostics, 76%, 100 mL single dose glass bottle, 10 count, NDC 00270-1316-35
  • Isovue-370 solution for injection, Bracco Diagnostics, 76%, 200 mL imaging bulk package glass bottle, 10 count, NDC 00270-1316-45
  • Isovue-370 solution for injection, Bracco Diagnostics, 76%, 500 mL imaging bulk package glass bottle, 6 count, NDC 00270-1316-95
  • Isovue-M 200 intrathecal solution for injection, Bracco Diagnostics, 41%, 10 mL single dose vial, 10 count, NDC 00270-1411-11
  • Isovue-M 300 intrathecal solution for injection, Bracco Diagnostics, 61%, 15 mL single dose vial, 10 count, NDC 00270-1412-15
  • Iopamidol solution for injection, Slate Run Pharmaceuticals, 41%, 10 mL vial, 10 count, NDC 70436-0124-82
  • Iopamidol solution for injection, Slate Run Pharmaceuticals, 41%, 20 mL vial, 10 count, NDC 70436-0124-52
  • Iopamidol solution for injection, Slate Run Pharmaceuticals, 61%, 100 mL single dose vial, 10 count, NDC 70436-0129-82
  • Iopamidol solution for injection, Slate Run Pharmaceuticals, 61%, 15 mL vial, 10 count, NDC 70436-0126-82
  • Iopamidol solution for injection, Slate Run Pharmaceuticals, 61%, 30 mL single dose vial, 10 count, NDC 70436-0129-52
  • Iopamidol solution for injection, Slate Run Pharmaceuticals, 61%, 50 mL single dose vial, 10 count, NDC 70436-0129-62
  • Iopamidol solution for injection, Slate Run Pharmaceuticals, 76%, 100 mL single dose vial, 10 count, NDC 70436-0127-82

Reason for the Shortage

• • Bracco has Isovue on shortage due to increased demand.
  • Slate Run has iopamidol on shortage due to increased demand.

Available Products

• • There is insufficient supply for usual ordering

• • Bracco has Isovue-M 200 and Isovue-M 300 available. All other presentations are on allocation. All Isovue presentations are available via direct orders only.
  • Slate Run has 41% iopamidol 10 mL vials on back order and the company estimates a release date of early- to mid-November 2026. The 61% iopamidol 15 mL vials are on back order and the company estimates a release date of late-October 2027. The 61% iopamidol 100 mL vials and 76% iopamidol 100 mL vials are on back order and the company estimates a release date of January 2027. The 41% iopamidol 20 mL vials, 61% iopamidol 30 mL vials, and 61% iopamidol 50 mL vials are on back order and the company cannot estimate a release date.